in a double-blind placebo-controlled study the encephalotropic and psychotropic properties of milacemide ( cp 1552 s ) - a new derivative of glycine showing anti-convulsant action by increasing gaba concentrations and endogenous glycine pools in the brain - were studied in 12 normal subjects by means of quantitative eeg and psychometric analyses .
C0086045
concentrations
C0006104
brain